Inhibition of mammalian cathepsins by Plesiomonas shigelloides

Folia Microbiologica

Volumn 51, Issue 5, 2006, Pages 393-400

  Pavlova, A ^a,e   Krovacek K ^b   Ciznar I ^c   Gonzalez Rey, C ^d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^c SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^d UPPSALA UNIVERSITY   (Sweden)

^e Biovica AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CATHEPSIN; CATHEPSIN B; CATHEPSIN L; CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; PAPAIN;

ANIMAL; ANTIGEN PRESENTATION; ARTICLE; CYTOPLASM; DRUG ANTAGONISM; HUMAN; IMMUNOLOGY; MAMMAL; METABOLISM; PATHOGENICITY; PLESIOMONAS;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, BACTERIAL; CATHEPSIN B; CATHEPSINS; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; HUMANS; MAMMALS; PAPAIN; PERIPLASM; PLESIOMONAS;

BACTERIA (MICROORGANISMS); MAMMALIA; PLESIOMONAS SHIGELLOIDES;

EID: 33751351923     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02931582     Document Type: Article

References (37)

1. BEERS C., BURICH A., KLEIJMEER M.J., GRIFFITH J.M., WONG P., RUDENSKY A.Y.: Cathepsin S controls MHC class II-mediated antigen presentation by epithelial cells in vivo. J.Immunol. 174, 1205-1212 (2005).
2. BJÖRK I., POL E., RAUB-SEGALL E., ABRAHAMSON M., ROWAN A.D., MORT J.S.: Differential changes in the association and dissociation rate constants for binding of cystatins to target proteinases occurring on N-terminal truncation of the inhibitors indicate that the interaction mechanism varies with different enzymes. Biochem.J. 299, 219-225 (1994).
3. BODE W., HUBER R.: Structural basis of the endoproteinase-protein inhibitor interaction. Biochim.Biophys.Acta 1477, 241-252 (2000).
4. ČIŽNÁR I., HOŠTACKÁ A., GONZALEZ-REY C., KROVAČEK K.: Potential virulence associated properties of Plesiomonas shigelloides strains. Folia Microbiol. 49, 543-548 (2004).
5. DALBØGE H., JENSEN E.B., TOTTRUP H., GRUBB A., ABRAHAMSON M., OLAFSSON I., CARLSEN S.: High-level expression of active human cystatin C in Escherichia coli. Gene 79, 325-332 (1989).
6. EGGERS C.T., MURRAY I.A., DELMAR V.A., DAY A.G., CRAIK C.S.: The periplasmic serine protease inhibitor ecotin protects bacteria against neutrophil elastase. Biochem.J. 379, 107-118 (2004).
7. FIEBIGER E., MAEHR R., VILLADANGOS J., WEBER E., ERICKSON A., BIKOFF E., PLOEGH H.L., LENNON-DUMENIL A.M.: Invariant chain controls the activity of extracellular cathepsin L. J.Exp.Med. 196, 1263-1269 (2002).
8. HARTMANN S., LUCIUS R.: Modulation of host immune responses by nematode cystatins. Internat.J.Parasitol. 33, 1291-1302 (2003).
9. HONEY K., RUDENSKY A.Y.: Lysosomal cysteine proteases regulate antigen presentation. Nature Rev.Immunol. 3, 472-482 (2003).
10. HSING L.C., RUDENSKY A.Y.: The lysosomal cysteine proteases in MHC class II antigen presentation. Immunol.Rev. 207, 229-241 (2005).
11. ILLY C., QURAISHI O., WANG J., PURISIMA E., VERNET T., MORT J.S.: Role of the occluding loop in cathepsin B activity. J.Biol.Chem. 272, 1197-1202 (1997).
12. AL, pp. 740-744 in G.M. Garrity (Ed.): Bergey's Manual of Systematic Bacteriology, 2nd ed. Springer-Verlag, New York 2005.
13. JIANG Z.D., NELSON A.C., MATHEWSON J.J., ERICSSON C.D., DUPONT H.L.: Intestinal secretory immune response to infection with Aeromonas species and Plesiomonas shigelloides among students from the United States in Mexico. J.Infect.Dis. 164, 979-982 (1991).
14. LAUTWEIN A., KRAUS M., REICH M., BURSTER T., BRANDENBURG J., OVERKLEEFT H.S., SCHWARZ G., KAMMER W., WEBER E., KALBACHER H., NORDHEIM A., DRIESSEN C.: Human B lymphoblastoid cells contain distinct patterns of cathepsin activity in endocytic compartments and regulate MHC class II transport in a cathepsin S-independent manner. J.Leukoc.Biol. 75, 844-855 (2004).
15. LINDAHL P., ABRAHAMSON M., BJÖRK I.: Interaction of recombinant human cystatin C with the cysteine proteinases papain and actinidin. Biochem.J. 281, 49-52 (1992).
16. LINEBAUGH B.E., SAMENI M., DAY N.A., SLOANE B.F., KEPPLER D.: Exocytosis of active cathepsin B. Enzyme activity at pH 7.0, inhibition and molecular mass. Eur.J.Biochem. 264, 100-109 (1999).
17. MASON R. W.: Species variants of cathepsin L and their immunological identification. Biochem.J. 240, 285-288 (1986).
18. MOLINARI M., SALIO M., GALLI C., NORAIS N., RAPPUOLI R., LANZAVECCHIA A., MONTECUCCO C.: Selective inhibition of Li-dependent antigen presentation by Helicobacter pylori toxin VacA. J.Exp.Med. 187, 135-140 (1998).
19. MUSIL D., ZUCIC D., TURK D., ENGH R.A., MAYR I., HUBER R., POPOVIC T., TURK V., TOWATARI T., KATUNUMA N., BODE W.: The refined 2.15 A X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity. EMBO J. 10, 2321-2330 (1991).
20. NÄGLER D.K., STORER A.C., PORTARO F.C., CARMONA E., JULIANO L., MENARD R.: Major increase in endopeptidase activity of human cathepsin B upon removal of occluding loop contacts. Biochemistry 36, 12608-12615 (1997).
21. ORTH K., XU Z., MUDGETT M.B., BAO Z.Q., PALMER L.E., BLISKA J.B., MANGEL W.F., STASKAWICZ B., DIXON J.E.: Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease. Science 290, 1594-1597 (2000).
22. PAVLOVA A., BJÖRK I.: Grafting of features of cystatins C or B into the N-terminal region or second binding loop of cystatin A (stefin A) substantially enhances inhibition of cysteine proteinases. Biochemistry 42, 11326-11333 (2003).
23. PAVLOVA A., KRUPA J.C., MORT J.S., ABRAHAMSON M., BJÖRK I.: Cystatin inhibition of cathepsin B requires dislocation of the proteinase occluding loop. Demonstration by release of loop anchoring through mutation of His110. FEBS Lett. 487, 156-160 (2000).
24. PETANCESKA S., CANOLL P., DEVI L.: Expression of rat cathepsin S in phagocytic cells. J.Biol.Chem. 271, 4403-4409 (1996).
25. POL E., OLSSON S.L., ESTRADA S., PRASTHOFER T.W., BJÖRK I.: Characterization by spectroscopic, kinetic and equilibrium methods of the interaction between recombinant human cystatin A (stefin A) and cysteine proteinases. Biochem.J. 311, 275-282 (1995).
26. RIGDEN D.J., MOSOLOV V.V., GALPERIN M.Y.: Sequence conservation in the chagasin family suggests a common trend in cysteine proteinase binding by unrelated protein inhibitors. Protein Sci. 11, 1971-1977 (2002).
27. SANDERSON S.J, WESTROP G.D., SCHARFSTEIN J., MOTTRAM J.C., COOMBS G.H.: Functional conservation of a natural cysteine peptidase inhibitor in protozoan and bacterial pathogens. FEBS Lett. 542, 12-16 (2003).
28. SCHIERACK P., LUCIUS R., SONNENBURG B., SCHILLING K., HARTMANN S.: Parasite-specific immunomodulatory functions of filarial cystatin. Infect.Immun. 71, 2422-2429 (2003).
29. SENDIDE K., DEGHMANE A.E., PECHKOVSKY D., AV-GAY Y., TALAL A., HMAMA Z.: Mycobacterium bovis BCG attenuates surface expression of mature class II molecules through IL-10-dependent inhibition of cathepsin S. J.Immunol. 175, 5324-5332 (2005).
30. STOCK I.: Plesiomonas shigelloides: an emerging pathogen with unusual properties. Rev.Med.Microbiol. 15, 129-139 (2004).
31. THEODOROPOULOS C., WONG T.H., O'BRIEN M., STENZEL D.: Plesiomonas shigelloides enters polarized human intestinal Caco-2 cells in an in vitro model system. Infect.Immun. 69, 2260-2269 (2001).
32. TURK D., GUNCAR G., PODOBNIK M., TURK B.: Revised definition of substrate binding sites of papain-like cysteine proteases. J.Biol. Chem. 379, 137-147 (1998).
33. TURK B., TURK D., TURK V.: Lysosomal cysteine proteases: more than scavengers. Biochim.Biophys.Acta 1477, 98-111 (2000).
34. TURK V., TURK B., TURK D.: Lysosomal cysteine proteases: facts and opportunities. EMBO J. 20, 4629-4633 (2001).
35. TURK V., TURK B., GUNCAR G., TURK D., KOS J.: Lysosomal cathepsins: structure, role in antigen processing and presentation, and cancer. Adv.Enzyme Regul. 42, 285-303 (2002a).
36. TURK B., TURK D., SALVESEN G.S.: Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators. Curr.Pharm.Des. 8, 1623-1637 (2002b).
37. VRAY B., HARTMANN S., HOEBEKE J.: Immunomodulatory properties of cystatins. Cell.Mol.Life Sci. 59, 1503-1512 (2002).